Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission

D Stolz, T Mkorombindo, DM Schumann, A Agusti… - The Lancet, 2022 - thelancet.com
Executive summary Despite substantial progress in reducing the global impact of many non-
communicable diseases, including heart disease and cancer, morbidity and mortality due to …

Personalized medicine for patients with COPD: where are we?

FME Franssen, P Alter, N Bar… - … journal of chronic …, 2019 - Taylor & Francis
Chronic airflow limitation is the common denominator of patients with chronic obstructive
pulmonary disease (COPD). However, it is not possible to predict morbidity and mortality of …

[HTML][HTML] Addressing challenges of economic evaluation in precision medicine using dynamic simulation modeling

DA Marshall, LR Grazziotin, DA Regier, S Wordsworth… - Value in health, 2020 - Elsevier
Objectives The objective of this article is to describe the unique challenges and present
potential solutions and approaches for economic evaluations of precision medicine (PM) …

A contextual ranking and selection method for personalized medicine

J Du, S Gao, CH Chen - Manufacturing & Service …, 2024 - pubsonline.informs.org
Problem definition: Personalized medicine (PM) seeks the best treatment for each patient
among a set of available treatment methods. Because a specific treatment does not work …

[HTML][HTML] Respiratory physiotherapy interventions focused on exercise training and enhancing physical activity levels in people with chronic obstructive pulmonary …

G Leemans, J Taeymans, P Van Royen… - Journal of Physiotherapy, 2021 - Elsevier
Question What is the cost-effectiveness of respiratory physiotherapy interventions for people
with chronic obstructive pulmonary disease? Design Systematic review of full economic …

How to address uncertainty in health economic discrete-event simulation models: an illustration for chronic obstructive pulmonary disease

I Corro Ramos, M Hoogendoorn… - Medical Decision …, 2020 - journals.sagepub.com
Background. Evaluation of personalized treatment options requires health economic models
that include multiple patient characteristics. Patient-level discrete-event simulation (DES) …

Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled …

M Hoogendoorn, IC Ramos, S Soulard, J Cook… - BMJ open, 2021 - bmjopen.bmj.com
Objectives Chronic obstructive pulmonary disease (COPD) guidelines advocate treatment
with combinations of long-acting bronchodilators for patients with COPD who have …

Modeling monthly migraine-day distributions using longitudinal regression models and linking quality of life to inform cost-effectiveness analysis: a case study of …

X Wang, K Yamato, Y Kojima, JJ Paris, EFP Peterse… - …, 2023 - Springer
Abstract Background and Objectives As regression approaches have been used more
recently to model the effectiveness and health-related quality of life (HRQOL) of novel …

[HTML][HTML] Modeling early warning systems: construction and validation of a discrete event simulation model for heart failure

FA de Almeida, IC Ramos, M Rutten-van Mölken, M Al - Value in Health, 2021 - Elsevier
Objectives Developing and validating a discrete event simulation model that is able to model
patients with heart failure managed with usual care or an early warning system (with or …

Patient pathway modelling using discrete event simulation to improve the management of COPD

U Yakutcan, E Demir, JR Hurst… - Journal of the Operational …, 2022 - Taylor & Francis
The number of people affected by chronic obstructive pulmonary disease (COPD) is
increasing and the hospital readmission rate is remarkably high. Therefore, healthcare …